Entering text into the input field will update the search result below

SAGE Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2021 Results - Earnings Call Transcript

May 04, 2021 2:18 PM ETSage Therapeutics, Inc. (SAGE)
SA Transcripts profile picture
SA Transcripts

SAGE Therapeutics, Inc. (NASDAQ:SAGE) Q1 2021 Earnings Conference Call May 4, 2021 8:00 AM ET

Company Participants

Jeff Boyle - Investor Contact

Barry Greene - President, CEO & Director

Stephen Kanes - Chief Medical Officer

Kimi Iguchi - CFO & Treasurer

Jim Doherty - Chief Research Officer

Conference Call Participants

Andrew Tsai - Jefferies

Ritu Baral - Cowen and Company

Tazeen Ahmad - Bank of America Merrill Lynch

Yasmeen Rahimi - Piper Sandler & Co.

Turner Kufe - JPMorgan Chase & Co.

Laura Chico - Wedbush Securities

Lie Ma - Wolfe Research

Jay Olson - Oppenheimer

Paul Matteis - Stifel, Nicolaus & Company

Andrea Tan - Goldman Sachs Group

Neena Bitritto-Garg - Citigroup

Evan Hua - BMO Capital Markets


Good morning. Welcome to Sage Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the investor and media section of Sage's website at sagerx.com. This call is property of Sage Therapeutics and recording, reproduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited. Please note this call is being recorded. I would now like to introduce Jeff Boyle, Vice President of Investor Relations at Sage.

Jeff Boyle

Good morning, and thank you for joining Sage Therapeutics' First Quarter 2021 Financial Results Conference Call. Before we begin, I encourage everyone to go to the investor and media section of our website at sagerx.com, where you can find the press release related to today's call as well as the slides that contain supplemental details. I'll point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please consult the risk factors discussed in today's press release and in our SEC filings for additional details.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.